PRESS RELEASE published on 07/22/2025 at 18:25, 10 months 29 days ago Amoéba launches a capital increase open to all to support its industrial and commercial deployment Amoéba, a greentech company, announces a capital increase of up to €14 million to support industrial and commercial growth in biocontrol and cosmetics. Key partners and subscription commitments outlined AMOEBA Capital Increase Biocontrol Cosmetics GreenTech
BRIEF published on 07/22/2025 at 17:50, 10 months 29 days ago Amoéba signs a strategic agreement with Metron Technology in China AMOEBA China Cosmetic Strategic Agreement Oriental Beauty Valley
BRIEF published on 07/22/2025 at 17:50, 10 months 29 days ago Amoéba signe un accord stratégique avec Metron Technology en Chine AMOEBA Cosmétique Accord Stratégique Chine Oriental Beauty Valley
PRESS RELEASE published on 07/22/2025 at 17:45, 10 months 29 days ago Amoéba signs an agreement with Metron Technology, a subsidiary of Oriental Beauty Valley (OBV), a key player in the cosmetics industry in China Amoéba signs agreement with Metron Technology, subsidiary of Oriental Beauty Valley, for cosmetic ingredient in China. Accelerating entry into second largest cosmetics market AMOEBA China Metron Technology Oriental Beauty Valley Cosmetic Ingredient
PRESS RELEASE published on 07/22/2025 at 17:45, 10 months 29 days ago Amoéba signe un accord avec Metron Technology, filiale du groupe Oriental Beauty Valley (OBV), acteur incontournable de la cosmétique en Chine Amoéba annonce un accord avec Metron Technology, filiale du groupe OBV, pour l'ingrédient cosmétique en Chine. Accélération du développement de l'activité cosmétique AMOEBA Développement Ingrédient Cosmétique Accord Metron Technology
BRIEF published on 06/25/2025 at 08:50, 11 months 26 days ago Dérogation obtenue par Amoéba pour son produit de biocontrôle AXP12 AMOEBA Biocontrôle Dérogation AXP12 ANSES
BRIEF published on 06/25/2025 at 08:50, 11 months 26 days ago Exemption obtained by Amoéba for its biocontrol product AXP12 AMOEBA Biocontrol Exemption AXP12 ANSES
PRESS RELEASE published on 06/25/2025 at 08:45, 11 months 26 days ago Exemption from the obligation to destroy crops in France obtained by Amoéba Amoéba receives experimental permit from ANSES for biocontrol product 'AXP12' against various crop diseases, exempt from crop destruction, marking significant progress in environmental-friendly solutions AMOEBA Biocontrol Environmentally Friendly ANSES Crop Diseases
PRESS RELEASE published on 06/25/2025 at 08:45, 11 months 26 days ago Dérogation à l'obligation de destruction des récoltes en France obtenue par Amoéba Amoéba reçoit une dérogation d'ANSES pour essais avec biocontrôle AXP12 contre maladies des cultures. Avancée majeure pour la greentech dans le domaine du biocontrôle et autorisations en cours AMOEBA Biocontrôle Dérogation ANSES Maladies Des Cultures
BRIEF published on 06/17/2025 at 18:05, 1 year ago Amoéba obtient l'approbation de sa substance active de biocontrôle en Europe AMOEBA Biocontrôle Agriculture Durable AXPERA Approbation Européenne
Published on 06/20/2026 at 01:00, 1 day 9 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 1 day 10 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 2 days 6 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 2 days 9 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 2 days 9 hours ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 21:25, 13 hours 25 minutes ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 1 day 4 hours ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 14 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 1 day 14 hours ago 2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 1 day 15 hours ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 19:33, 1 day 15 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 1 day 15 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 15 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 1 day 15 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026